CONTENTS 2011, Vol. XXXI, No 184, OCTOBER
...
CONTENTS 2011, Vol. XXXI, No 184, OCTOBER
EDITORIAL
Kozielski J.: Management of bacterial exacerbations of obstructive lung diseases 201
ORIGINAL PAPERS
Tenderenda E., Korzeniecka-Kozerska A., Porowski T., Wasilewska A., Zoch-Zwierz W.: Serum and urinary homocysteine in children with steroide-dependent nephrotic syndrome 204
Drewniak T., Juszczak K., Maciukiewicz P., Wyczółkowski M.: Evaluation of 99mTc-DTPA scyntygraphy of the relative degree of renal dysfunction after surgical removal of kidney tumor 209
Huk-Kolega H., Piechota A., Kleniewska P., Michalski Ł., Gorąca A.: The influence of lipoic acid on total protein concentration in the liver and spleen tissue in rats during lipopolysaccharide-induced oxidative stress 212
Kardas P.: Prevalence of non-adherence to medication among patients treated for selected chronic conditions 215
CASE REPORTS
Piechota M., Dąbek J., Lepich T., Sielańczyk A.: Brugada Syndrome – case report 221
Elikowski W., Małek M., Witczak W., Wróblewski D., Kozłowski T., Dziarmaga M.: Takotsubo cardiomyopathy as a consequence of gastrointestinal disorder – a case preceded by exacerbation of gastroesophageal reflux disease 227
Cichoż-Lach H., Kowalik A., Kuć K., Starosławska E., Słomka M.: Ascites as the first manifestation of ovarian cancer in the disseminated stage – case report 233
Mroczkowska-Juchkiewicz A., Gołyska D., Pawłowska-Kamieniak A., Pac-Kożuchowska E.: Chronic constipation in children – typical and atypical diagnoses – case reports 236
REVIEW PAPERS
Cichosz G., Czeczot H.: Spuriously healthy plant fats 239
Hen K., Bogdański P., Pupek-Musialik D.: Osteoprotegerin – a new atherosclerosis marker 244
Gryglewski A., Kibil W., Hodorowicz-Zaniewska D., Walocha J.: Sentinel lymph node biopsy as a new approach to colorectal cancer treatment 249
Ogłodek E., Araszkiewicz A.: The main directions of research on the causes conditioning the occurrence of the borderline personality disorders 252
Gałecki P., Depko A., Woźniak A., Talarowska M.: Depressive disorder, treatment and sexual dysfunction – Part II 256